ContextVision AB – Mandatory notification of trade

ContextVision AB – Mandatory notification of trade

Stockholm, February 25th, 2016

Monsun AS, controlled by Magne Jordanger, board member and primary insider in ContextVision AB, has on February 24th, 2016 purchased 33 750 shares in ContextVision AB at a price of NOK 24,50 per share. Following this transaction, Monsun AS owns 2 248 750 shares in ContextVision AB.

For inquires please contact CEO Anita Tollstadius;
anita.tollstadius@contextvision.se

This information is subject to the disclosure requirements pursuant to the
Norwegian Securities Trading Act.

About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.

Download pdf »